Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer

NCT00071357 is registered in ClinicalTrials.gov with National Institute of Neurological Disorders and Stroke (NINDS) as lead sponsor.

NCT NCT00071357
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00071357 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of Dynamic Contrast-Enhanced Magnetic Resonance Imaging to Assess Tumor-Associated Vasculature in Patients With Metastatic Breast Cancer
Lead sponsor
National Institute of Neurological Disorders and Stroke (NINDS)
Phase
Observational
Overall status
Completed
Start date
October 31, 2003
Completion date
October 31, 2004
Enrollment
78
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast neoplasms